Interleukin-10 and the immune response against cancer: a counterpoint-Reference-Cited by-同舟云学术

Interleukin-10 and the immune response against cancer: a counterpoint

Published:2005-10-04 Issue:5 Volume:78 Page:1043-1051
ISSN:0741-5400
Container-title:Journal of Leukocyte Biology
language:en
Short-container-title:Journal of Leukocyte Biology

Author:

Mocellin Simone,Marincola Francesco M.,Young Howard A.

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Reference131 articles.

1. Cytokines and immune response in the tumor microenvironment;Mocellin;J. Immunother.,2001

2. Interleukin-10 in viral diseases and cancer: exiting the labyrinth?;Vicari;Immunol. Rev.,2004

3. Ammonium trichloro(dioxoethylene-o,o')tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop;Sredni;Cancer Res.,2004

4. Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis;Alas;Clin. Cancer Res.,2001

5. Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for Hodgkin's disease;Bohlen;Ann. Hematol.,2000

Cited by 319 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunologic Mechanisms of BCc1 Nanomedicine Synthesized by Nanochelating Technology in Breast Tumor-Bearing Mice: Immunomodulation and Tumor Suppression;Anti-Cancer Agents in Medicinal Chemistry;2024-07-26

2. Anticancer effect of propranolol on diethylnitrosamine‐induced hepatocellular carcinoma rat model;Fundamental & Clinical Pharmacology;2024-02-07

3. ω-3 polyunsaturated fatty acid alleviates systemic lupus erythematosus by suppressing autoimmunity in a murine model;International Immunopharmacology;2024-01

4. A dual-role for IL-10: From leukemogenesis to the tumor progression in acute lymphoblastic leukemia;Cytokine;2023-11

5. Serum cytokines and neutrophil-to-lymphocyte ratio as predictive biomarkers of benefit from PD-1 inhibitors in gastric cancer;Frontiers in Immunology;2023-10-31